Ignite Creation Date:
2025-12-26 @ 10:34 AM
Ignite Modification Date:
2026-03-08 @ 11:03 PM
Study NCT ID:
NCT01461928
Status:
COMPLETED
Last Update Posted:
2019-08-06
First Post:
2011-10-19
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study Comparing Maintenance Subcutaneous Rituximab With Observation Only in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Had Responded to Rituximab-based Immunochemotherapy Induction and 2-year Maintenance With Subcutaneous Rituximab
Sponsor:
Hoffmann-La Roche
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Non-Hodgkin's Lymphoma | View |
Keywords: